Reynish Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.85 Cr
as on 16-11-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 66.05%
(FY 2023)
- Profit -107.39%
(FY 2023)
- Ebitda -125.34%
(FY 2023)
- Net Worth -0.07%
(FY 2023)
- Total Assets 0.04%
(FY 2023)
About Reynish Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bharat Boghara, Parulbhai Patel, Natwarlal Navadiya, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U24303GJ2018PTC101595
- Company No.
101595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationVadodara, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reynish Pharmachem?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Boghara  | Director | 02-Apr-2018 | Current |
| Parulbhai Patel | Director | 02-Apr-2018 | Current |
| Natwarlal Navadiya | Director | 10-May-2018 | Current |
| Tarakbhai Patel | Director | 07-Dec-2018 | Current |
| Kuntal Shah | Director | 10-May-2018 | Current |
| Amitkumar Patel | Director | 02-Apr-2018 | Current |
Financial Performance of Reynish Pharmachem.
Reynish Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.05% increase. The company also saw a substantial fall in profitability, with a 107.39% decrease in profit. The company's net worth dipped by a decrease of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reynish Pharmachem?
In 2023, Reynish Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
.webp)
Nishant Organics Private LimitedActive 30 years 1 monthParulbhai Patel, Tarakbhai Patel and 1 more are mutual person
Nb Healthcare Private LimitedActive 5 years 3 monthsBharat Boghara and Nalinkumar Patel are mutual person
M. M. Yarns Private LimitedActive 10 years 7 monthsBharat Boghara, Natwarlal Navadiya and 2 more are mutual person
Dhruv Cotton Processing Private LimitedActive 17 years 9 monthsBharat Boghara, Parulbhai Patel and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reynish Pharmachem?
Unlock and access historical data on people associated with Reynish Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reynish Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reynish Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
